BATA:PSXBata Pakistan Limited Analysis
Data as of 2026-08-01 - not real-time
₹696.15
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Bata India’s share price is trading just below its 20‑day and 50‑day simple moving averages, confirming a short‑term bearish bias despite a bullish MACD histogram and a neutral RSI that suggests limited upside momentum. Volatility remains elevated at roughly 24% over the past month, while the stock’s beta is exceptionally low, indicating limited correlation with broader market moves. The company’s valuation appears stretched, with a price‑to‑earnings multiple well above 60 and a DCF‑derived fair value considerably lower than the current market price. Fundamentally, revenue is growing modestly, margins are respectable, and free cash flow is healthy, yet the balance sheet is burdened by a debt‑to‑equity ratio approaching 87%, raising concerns about leverage sustainability. The dividend payout sits near 86% of earnings, which, combined with the high debt load, questions the long‑term durability of the yield. Overall, the stock sits at a crossroads where technical signals are mixed, valuation is premium, and financial risk is notable.
Looking ahead, the forward earnings outlook shows a substantial uplift, hinting at potential earnings acceleration that could justify a higher multiple if growth materializes. However, the immediate upside is limited by the proximity to a key support level and the prevailing overvalued pricing. The dividend remains attractive in a low‑interest‑rate environment, but its sustainability hinges on the company’s ability to manage debt and maintain cash generation. Investors should weigh the strong brand and cash flow against the elevated valuation and leverage when forming a position.
Looking ahead, the forward earnings outlook shows a substantial uplift, hinting at potential earnings acceleration that could justify a higher multiple if growth materializes. However, the immediate upside is limited by the proximity to a key support level and the prevailing overvalued pricing. The dividend remains attractive in a low‑interest‑rate environment, but its sustainability hinges on the company’s ability to manage debt and maintain cash generation. Investors should weigh the strong brand and cash flow against the elevated valuation and leverage when forming a position.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish price trend relative to moving averages
- Proximity to technical support level
- High valuation relative to DCF fair value
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong forward earnings growth projection
- Robust free cash flow generation
- Attractive dividend yield despite leverage
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Established brand and distribution network
- Persistent high debt levels
- Potential for earnings multiple compression if growth stalls
Key Metrics & Analysis
Financial Health
Revenue Growth5.00%
Profit Margin3.82%
P/E Ratio66.7
ROE8.47%
ROA5.22%
Debt/Equity86.90
P/B Ratio5.6
Op. Cash Flow₹5.9B
Free Cash Flow₹4.4B
Technical Analysis
TrendBearish
RSI51.3
Support₹664.90
Resistance₹717.50
MA 20₹689.32
MA 50₹690.37
MA 200₹821.61
MACDBullish
VolumeStable
Fear & Greed Index92.88
Valuation
Fair Value₹481.58
Target Price₹724.69
Upside/Downside4.10%
GradeOvervalued
TypeBlend
Dividend Yield1.29%
Risk Assessment
Beta0.19
Volatility23.76%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.